H.R. 873 (111th): Stem Cell Research Enhancement Act of 2009

Introduced:
Feb 04, 2009 (111th Congress, 2009–2010)
Status:
Died (Referred to Committee)
See Instead:

S. 487 (same title)
Referred to Committee — Feb 26, 2009

Sponsor
Diana DeGette
Representative for Colorado's 1st congressional district
Party
Democrat
Text
Read Text »
Last Updated
Feb 04, 2009
Length
3 pages
Related Bills
H.R. 3 (110th) was a previous version of this bill.

Passed House
Last Action: Jan 11, 2007

S. 487 (Related)
Stem Cell Research Enhancement Act of 2009

Referred to Committee
Last Action: Feb 26, 2009

 
Status

This bill was introduced on February 4, 2009, in a previous session of Congress, but was not enacted.

Progress
Introduced Feb 04, 2009
Referred to Committee Feb 04, 2009
 
Full Title

To amend the Public Health Service Act to provide for human embryonic stem cell research.

Summary

No summaries available.

Cosponsors
114 cosponsors (107D, 7R) (show)
Committees

House Energy and Commerce

Health

The committee chair determines whether a bill will move past the committee stage.

 
Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.

Widget

Get a bill status widget for your website »

Citation

Click a format for a citation suggestion:

Notes

H.R. stands for House of Representatives bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.


2/4/2009--Introduced.
Stem Cell Research Enhancement Act of 2009 - Amends the Public Health Service Act to require the Secretary of Health and Human Services to conduct and support research that utilizes human embryonic stem cells, regardless of the date on which the stem cells were derived from a human embryo.
Limits such research to stem cells that meet the following requirements:
(1) the stem cells were derived from human embryos donated from in vitro fertilization clinics, were created for the purposes of fertility treatment, and were in excess of the needs of the individuals seeking such treatment;
(2) prior to donation, it was determined that the embryos would never be implanted in a woman and would otherwise be discarded; and
(3) the individuals seeking fertility treatment donated the embryos with written informed consent and received no financial or other inducements.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.


No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of H.R. 873 (111th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus